KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Debt to Equity (2016 - 2024)

Historic Debt to Equity for Exact Sciences (EXAS) over the last 16 years, with Q1 2024 value amounting to $0.02.

  • Exact Sciences' Debt to Equity fell 239.13% to $0.02 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.02, marking a year-over-year decrease of 239.13%. This contributed to the annual value of $0.02 for FY2023, which is 324.75% down from last year.
  • Latest data reveals that Exact Sciences reported Debt to Equity of $0.02 as of Q1 2024, which was down 239.13% from $0.02 recorded in Q4 2023.
  • Exact Sciences' Debt to Equity's 5-year high stood at $0.02 during Q4 2022, with a 5-year trough of $0.01 in Q1 2021.
  • Its 5-year average for Debt to Equity is $0.01, with a median of $0.02 in 2023.
  • Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 9791.85% in 2020, then soared by 15941.17% in 2022.
  • Over the past 5 years, Exact Sciences' Debt to Equity (Quarter) stood at $0.01 in 2020, then crashed by 37.96% to $0.01 in 2021, then surged by 164.99% to $0.02 in 2022, then decreased by 3.25% to $0.02 in 2023, then rose by 0.4% to $0.02 in 2024.
  • Its Debt to Equity stands at $0.02 for Q1 2024, versus $0.02 for Q4 2023 and $0.02 for Q3 2023.